TheFly

Goldman Sachs upgraded Nio (NIO) to Neutral from Sell with a $3.80 price target Published first on TheFly...

As previously reported, GLJ Research analyst Gordon Johnson downgraded Sunrun (RUN) to Sell from Hold with a 1c...

Goldman Sachs upgraded XPeng (XPEV) to Buy from Neutral with a $24 price target Published first on TheFly...

PureCycle Technologies (PCT) announced the plan to bring one billion pounds of installed capacity online before 2030 across...

Vertical Research initiated coverage of Nordson (NDSN) with a Hold rating and $245 price target Published first on...

RBC Capital analyst Brian Abrahams lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $420 from $423...

William Blair downgraded Cantaloupe (CTLP) to Market Perform from Outperform after the company agreed to be acquired by...

Susquehanna raised the firm’s price target on TSMC (TSM) to $255 from $250 and keeps a Positive rating...

BofA raised the firm’s price target on Paychex (PAYX) to $135 from $132 and keeps an Underperform rating...

Aldebaran Resources (ADBRF) provides results of 11 holes from the in-fill drilling program currently being completed at the...

JPMorgan analyst Anthony Paolone raised the firm’s price target on Camden Property (CPT) to $129 from $127 and...

BTIG raised the firm’s price target on Darden (DRI) to $235 from $210 and keeps a Buy rating...

JPMorgan lowered the firm’s price target on AvalonBay (AVB) to $249 from $251 and keeps an Overweight rating...

JPMorgan analyst James Gordon raised the firm’s price target on Grifols (GRFS) to $10.30 from $7.60 and keeps...

Morgan Stanley initiated coverage of Monday.com (MNDY) with an Equal Weight rating and $330 price target Moving upmarket,...

Moolec Science (MLEC) announced the successful closing of its previously announced strategic business combination with Bioceres Group, Gentle...

Idaho Strategic (IDR) Resources announced its inclusion in the preliminary list of additions to the broad-market Russell 3000...

Insight Molecular Diagnostics (IMDX) announced its renaming and the relocation of its principal executive office from Irvine, California,...

Craig-Hallum analyst George Sutton downgraded Cantaloupe (CTLP) to Hold from Buy with a $11.20 price target after the...

GLJ Research downgraded Sunrun (RUN) to Sell from Hold with a 1c price target Published first on TheFly...

B. Riley downgraded Cantaloupe (CTLP) to Neutral from Buy with a price target of $11.20, down from $11.50,...

TB2 Aerospace, in collaboration with Draganfly (DPRO), announces the successful deployment and performance of the Drone Recharging Operational...

BTIG analyst Andre Madrid raised the firm’s price target on BWX Technologies (BWXT) to $155 from $140 and...

JPMorgan raised the firm’s price target on Carpenter Technology (CRS) to $305 from $245 and keeps an Overweight...

Lifecore (LFCR) Biomedical announced that it has signed a new 10-year commercial manufacturing and supply agreement with a...

Goldman Sachs analyst Salveen Richter downgraded Sarepta (SRPT) to Neutral from Buy with a $29 price target Published...

Purple Biotech (PPBT) announced the initiation of a Phase 2 clinical study evaluating NT219 in patients with recurrent...

Unicycive Therapeutics (UNCY) announced that it will implement a 1-for-10 reverse split of the issued shares of its...

Kraft Heinz (KHC) announced it will not launch any new products in the U.S. with food, drug and...

Guggenheim analyzed the details of the Senate Finance Committee’s draft of tax language for the proposed Republican megabill...

D-Wave Quantum (QBTS) announced that it has signed a memorandum of understanding with Yonsei University and Incheon Metropolitan...

Whitestone REIT (WSR) announced it has acquired 5000 South Hulen, a 86,907 square-foot shopping center located in Fort...

Goldman Sachs downgraded Sarepta (SRPT) to Neutral from Buy with a price target of $29, down from $100....

Deutsche Bank analyst David Hoang lowered the firm’s price target on Sarepta (SRPT) to $25 from $50 and...

The deal size was increased to $260M from $200M and priced at low end of $16.75-$17.75 range. JPMorgan,...

Deutsche Bank raised the firm’s price target on ViaSat (VSAT) to $16 from $14 and keeps a Buy...

Beneficient (BENF) announced that the Bankruptcy Court for the Southern District of Texas has approved the previously disclosed...

Mobix Labs (MOBX) announced a surge in customer bookings, underscoring and accelerating demand across its Defense and Aerospace...

Lantronix (LTRX) announced its collaboration with Aerora, a provider of integrated NDAA-compliant propulsion, ground control and precision AI...

Craig-Hallum initiated coverage of Neurogene (NGNE) with a Buy rating and $50 price target Published first on TheFly...

Fresenius Medical (FMS) unveiled its new FME Reignite strategy at its Capital Markets Day in London. FME Reignite...

RBC Capital initiated coverage of EyePoint (EYPT) with an Outperform rating and $28 price target The firm thinks...

Ventyx Biosciences (VTYX) announced positive top-line results from its Phase 2a study of VTX3232, a novel, CNS-penetrant NLRP3...

Kirkland’s (KIRK) announced plans to rebrand and change its corporate name from Kirkland’s to “The Brand House Collective,”...

Kamada (KMDA) announced that, while circumstances in the Middle East are evolving, the Company is continuing the operations...

Canaccord raised the firm’s price target on Sage Therapeutics (SAGE) to $8.50 from $8 and keeps a Hold...

Canaccord analyst Sumant Kulkarni raised the firm’s price target on Sage Therapeutics (SAGE) to $8.50 from $8 and...

Aldeyra (ALDX) announced the resubmission of a new drug application to the FDA for topical ocular reproxalap, an...

Vireo Growth (VREOF) announced a series of corporate updates following the closing of all its previously-announced definitive merger...

Acurx (ACXP) Pharmaceuticals’ lead antibiotic candidate, ibezapolstat, is ready to advance to international Phase 3 clinical trials for...